However, behavioral therapies such as contingency management, cognitive-behavioral, and motivational enhancement therapies, are only moderately effective
Safety assessments included adverse events, hypoglycaemic episodes, vital signs, electrocardiogram, clinical laboratory assessments, physical examination and anti-icodec and anti-semaglutide antibodies
Common adverse reactions to Wegovy include nausea (reported in up to 44% of patients during clinical trials according to the MHRA SmPC), vomiting, diarrhoea, constipation, and abdominal discomfort
Understanding Semaglutide Semaglutide is a prescription medication originally developed to treat type 2 diabetes it works by mimicking a hormone in the body called glucagon-like peptide-1 (GLP-1) that helps regulate blood sugar levels